Cargando…
Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy
Doxorubicin (DOX) is one of the most effective chemotherapeutic agents. However, its clinical use is limited due to the severe risk of cardiotoxicity. One of the hallmarks of doxorubicin-induced cardiotoxicity (DICT) is the cascade of mitophagy deficiency-mitochondrial oxidative injury-apoptosis, wh...
Autores principales: | Li, Weili, Wang, Xiaoping, Liu, Tianhua, Zhang, Qian, Cao, Jing, Jiang, Yanyan, Sun, Qianbin, Li, Chun, Wang, Wei, Wang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867983/ https://www.ncbi.nlm.nih.gov/pubmed/35223843 http://dx.doi.org/10.3389/fcell.2022.813370 |
Ejemplares similares
-
Neuraminidase1 Inhibitor Protects Against Doxorubicin-Induced Cardiotoxicity via Suppressing Drp1-Dependent Mitophagy
por: Qin, Yating, et al.
Publicado: (2021) -
Qishen Granule Protects against Doxorubicin-Induced Cardiotoxicity by Coordinating MDM2-p53-Mediated Mitophagy and Mitochondrial Biogenesis
por: Li, Weili, et al.
Publicado: (2022) -
Endosomal Rab cycles regulate Parkin-mediated mitophagy
por: Yamano, Koji, et al.
Publicado: (2018) -
Exosomes Regulate Interclonal Communication on Osteogenic Differentiation Among Heterogeneous Osteogenic Single-Cell Clones Through PINK1/Parkin-Mediated Mitophagy
por: Fei, Dongdong, et al.
Publicado: (2021) -
Mechanisms and Drug Intervention for Doxorubicin-Induced Cardiotoxicity Based on Mitochondrial Bioenergetics
por: Ling, Guanjing, et al.
Publicado: (2022)